Skip to main content
. 2019 Sep 3;33(5):1485–1492. doi: 10.21873/invivo.11628

Table III. Targeted sequencing results: Tumor protein 53 (TP53) mutations.

graphic file with name in_vivo-33-1489-i0002.jpg

IDS: Interval debulking surgery; IHC: immunohistochemical staining; LSO: left salpingo-oophorectomy; NA: not applicable; NAC: Neoadjuvant chemotherapy; NC: negative control; PC: positive control; PDS: primary debulking surgery; POAC: postoperative adjuvant chemotherapy; SDS: secondary debulking surgery.